deferoxamine has been researched along with Focal Segmental Glomerulosclerosis in 3 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
van Swelm, RPL | 1 |
Beurskens, S | 1 |
Dijkman, H | 1 |
Wiegerinck, ETG | 1 |
Roelofs, R | 1 |
Thévenod, F | 1 |
van der Vlag, J | 1 |
Wetzels, JFM | 1 |
Swinkels, DW | 1 |
Smeets, B | 1 |
Keane, WF | 1 |
O'Donnell, MP | 1 |
Kasiske, BL | 1 |
Kim, Y | 1 |
Kawamoto, S | 1 |
Kawamura, T | 1 |
3 other studies available for deferoxamine and Focal Segmental Glomerulosclerosis
Article | Year |
---|---|
Kidney tubule iron loading in experimental focal segmental glomerulosclerosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Deferoxamine; Disease Models, Animal; | 2022 |
Oxidative modification of low-density lipoproteins by mesangial cells.
Topics: Antioxidants; Arachidonic Acid; Butylated Hydroxytoluene; Catalase; Cell Division; Cells, Cultured; | 1993 |
[A role for reactive oxygen species in the pathogenesis of focal glomerulosclerosis].
Topics: Animals; Deferoxamine; Glomerulosclerosis, Focal Segmental; Macrophages; Male; Rats; Rats, Sprague-D | 1996 |